Drugs / BX002-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04737876 | Oct → Dec 2020 | — | BiomX, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BX002-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04737876 ↗ |
| Route | Oral | “orally administered BX002-A” NCT04737876 ↗ |